Our top 30 startups from Web Summit 2021

Sustainable startups

CauliBox

This London-based start-up hopes to disrupt the urban food industry by helping customers and restaurants shift to reusable packaging. The reusable lunchbox scheme has the potential to save 15m single-use takeaway containers every year.

Starting with a 10-person trial, the scheme now has over 250 members, where city professionals and food vendors can enjoy street food at lunch without the environmental downfall.

www.caulibox.com

Carbon Limits

Carbon Limits is turning CO2 pollution into profits. By working with public authorities, private companies, financial institutions to reduce emissions, the Norwegian startup also supports clients to finance projects that mitigate climate change and generate economic value.

www.carbonlimits.no

WhyWaste

According to the UN, 30% of all food production is wasted before human consumption – despite 821m people living in starvation. WhyWaste is an app based in Brazil that uses data to control expiration dates and help food companies to reduce their losses.

The startup is used in 12 countries across the globe and the loss prevention technology is used by thousands of stores of retail chains, enabling a reduction in food waste, greater productivity and operational efficiency.

www.whywaste.com.br

Bioworld

Bioworld creates circular and sustainable business models for innovative product solutions, creating, capturing and delivering value throughout the product lifecycle.

Through consultancy, training and innovation, the startup ensures innovation and sustainability for clients.

www.bioworld.pt/en/homepage/

Changing Room

Changing Room empowers consumers to reduce their environmental impact by giving them transparency on their purchases and suggesting lower-impact alternatives. The startup provides a gamified experience that allows people to celebrate progress towards a sustainable lifestyle and find out just how much their clothing is impacting the environment.

www.changingroom.eco/

Full&Fast

Full&Fast believe in a future in which the right clean energy management will allow new generations to enjoy a more sustainable planet. With innovation at the core of their work, they provide clients with renewable technologies that will add value.

www.fullandfast.com/

EcoTree

This startup allows users to instantly buy trees around the world, follow its progress, and when it’s time for the tree to be cut down and sold for sustainable timber, users will receive a profit.

www.ecotree.green/en/

Health

GlycanAge

GlycanAge provides users with longevity biological tests that focuses on the inflammation of Glycans to help detect early signs of disease. The aim of the tests are to help people age well and improve their lifestyle.

https://glycanage.com

Nexus Digital Technology

This is the non-prescriptive digital behaviour modification that empowers users to take control of their health and wellbeing.

www.nexus-dt.com/

Maindcare

This Italian startup combines AI with a proprietary wearable to prevent chronic stress for users and offers daily personalised activities based on gamification. The unique method can set the baseline stress level and use AI-driven Algorithm to extract stress peaks.

www.maindcare.com/

RAW

This app is the one-stop platform for runners. It combines a training platform with a social network and also allows users to search and sign up for races.

www.letsraw.com/

Fintech

Numur

Numur is a national investment company that provides innovative services such as credit lines, leasing lines, automachine and student loans with fast, easy, flexible terms and conditions.

www.numur.mn/en/

EthicHub

This Madrid-based startup connects small farmers with international lenders and buyers, based on its Ethix token and to build collateral and incentives.

www.ethichub.com

PitchedIt

PitchedIt is building an alternative to crowdfunding platforms, which have set the barrier to entry too high for most early-stage founders to even get their ideas heard. It is a community-powered fundraising platform for early-stage founders and investors, which takes ideas to launch and beyond.

www.pitchedit.co/

Finmap

Finnmap is a cashflow management tool that provides simple visual tools to help business owners manages their finances. Finmap integrates seamlessly with hundreds of other apps including Paypal and Wise.

https://finmap.online/en

Steakwallet

Steakwallet is a multi-chain wallet that makes staking your crypto as easy as possible. Send, receive, stake, delegate and more all from your personal Steakwallet.

www.steakwallet.fi/

Finoa

The startup offers a wallet for your crypto assets alongside a user-friendly platform providing portfolio coverage for both institutional and corporate customers. The API allows users to integrate the digital wallet with their own applications.

www.finoa.io/

Education

Zzish

Zzish is a global education platform for teachers that uses machine learning to help learning in the classroom and at home. Zzish uses gamification and spaced repetition to help aid memory.

www.zzish.com/

Growappy

Growappy is the app that aims to revolutionize the communication experience between schools and families, strengthening their sense of community.

www.growappy.com/home

Key2Enable

Key2Enable develops technology to assist people with disabilities to develop their skills and individualities. Based on assistive projects first developed in Brazil back in 2015, the platform uses exponential technologies to give autonomy to people with motor and intellectual disabilities around the world.

www.key2enable.com/

Twin Science

This is the programme that equip kids with the tools and knowledge they need to overcome tomorrow’s biggest challenges. So far, they have taught over 400,000 children and supported 1,200 schools using playful and individual learning techniques.

www.twinscience.com/en/

Wuolah

Over a million students already use Wuolah, the platform that allows people to upload and share study materials. Help your classmates and also receive money for downloads.

www.wuolah.com/

Gaming

Infinity Games

Infinity Games creates immersive experiences, providing games that are simple, relaxing and minimalistic. Download one of the many games already on the app store.

www.infinitygames.io/

Haptology

This gaming experience consists of a double modality for Immersive Presence Controller; gesture and tactile control. The wireless, ergonomic ring enables to emulate the sense of touch and gesture recognition in cross-platform, 2D/3D applications, which allows users to interact with digital content in a natural and intuitive way.

www.haptology.com/

Black Snow

Combines physical and digital realities using just your smartphone. Turn on your camera to enjoy immersive AR at your location and play with friends.

www.blacksnow.tv/

MaxSens Innovations

MaxSens Innovations is the platform that allows you to train virtually for real life events. With innovative virtual reality tools, employees can master new skills faster and more effectively than ever.

www.maxsens-innovations.com/en/

VRpartments

VRpartments allow users to browse and furnish apartments without leaving the house. Users can see apartments from anywhere using virtual reality technology, saving time and money.

www.vrpartments.com/

Media

Frame Media

Frame Media is an award-winning news publication dedicated to exploring the unseen sides of the biggest issues of our time. They tell stories in unconventional and immersive formats, aiming to foster a deeper understanding of the news.

www.frame.media/

Producer

Producer is the all in one workspace for media production. The Swiss startup assists ambitious filmmakers, creatives, storytellers, and teams to get full control in managing the complexity of developing and executing a successful production.

www.the-producer.io/

UShowMe

This is the platform that amplifies live shows beyond venues. It provides new interactive experiences and revenues for creators.

www.ushowme.tv/

Cineworld demand grows, revenues rise

0

In its most recent trading update, Cineworld has reported 90% of pre-pandemic revenues.

On 2019 levels, revenues were 129% up and the cinema said that demand had steadily increased across UK and Ireland. Films including the latest James Bond and Black Widow had boosted the group’s recovery.

“James Bond has come to the rescue of Cineworld, helping its UK and Irish cinemas in October to beat box office and concession revenue levels seen in the same month two years earlier, before the pandemic struck,” said AJ Bell investment director Russ Mould.

“No Time To Die has encouraged people to try the cinema again, although the master spy was unable to crack the code for similar success in the US and other Cineworld territories where October’s takings didn’t surpass the comparative period two years earlier.”

With COVID-19 restrictions in the rear view mirror in the UK and the US moving in the same direction, cinema goers have take the opportunity to return to watch on the big screens.

“We are thrilled to see audiences returning in significant numbers. Our partnerships with the studios are as strong as ever and with the incredible movie slate to come, there are real grounds for optimism in our industry,” said chief executive, Mooky Greidinger.

“Whilst there are challenges ahead, I believe these efforts have positioned us for great success in the future and we are all looking forward to continuing to welcome our customers to the best place to watch a movie.”

Films that are coming out ahead of Christmas that are expected to boost Cineworld demand include Spider-Man, Top Gun and The Matrix.

New AIM admission: Firering’s lithium potential

Firering Strategic Minerals is emphasising the lithium potential of the Atex project, but the potential columbite-tantalite (coltan) resource should also be lucrative.
It is no surprise to investors that lithium demand is increasing as more electric vehicles are produced and they require batteries. The coltan is also used in electric vehicles as well as other consumer electronics.
The Atex project is still at an early stage and the cash raised in the placing will finance mapping and initial drilling. Recent sampling has shown high grade samples. There also plans for pilot production of coltan....

New standard listing: PYX obtains dual listing

PYX Resources Ltd (LON: PYX) is already quoted on the NSX in Australia and it wants to tap into an investor base in the UK that is experienced in the mining sector.
PYX is in a strong position as the second largest resources of zircon in the world with zircon prices increasing and demand remaining strong. An undersupply of zircon is anticipated so there will be plenty of demand.
There is plenty of cash for immediate needs even though none was raised in the introduction to the standard list. Management intends to increase zircon production at Mandiri and start production at Tisma. There are als...

Newmark Security: Director Dealings

Director Dealings – A  very small sign of Recovery
Newmark Security (LSE: NWT) Mkt Cap £4.46m
Roger Waddington only brought 500,000 shares at 0.8p a mere £4000 worth and fter the recent share consolidation of 50 into 1- the new in price is 40p. This takes his holding to  5m shares which is around 1% .  
It seems a small amount but given the recent trading update it’s a wonder he brought at all.
Robert is a chartered accountant who has worked for many years in investment banking and has experience of the betting and gaming, property investment and engineering ...

FTSE 100 fails to touch pre-pandemic highs

The FTSE 100 fell on Friday as the UK’s leading index failed to continue a rally to the highest levels since the beginning of the pandemic.

Having closed at 7,384 on Thursday, the FTSE 100 was within touching distance of the key level of 7,403. However, the index fell on Friday with heavyweights including AstraZeneca, Shell and BP softening on Friday morning.

The FTSE 100 was trading at 7,349, down 34 points in mid-morning trade on Friday.

“The FTSE 100 is on the cusp of finally hitting its pre-pandemic levels, nearly two years after the global market crash of February 2020,” says Russ Mould, investment director at AJ Bell.

“This has been a long time coming and somewhat embarrassing for the UK’s market reputation because the Nasdaq Composite in the US managed to claw back all its Covid-related market losses in just a matter of months – by 2 June 2020 it was trading ahead of the pre-pandemic levels.”

“The magic number for the FTSE 100 to surpass is 7,403.92 which is the market closing price on Friday 21 February 2020. When the market opened the following Monday, it began a dramatic fall which saw the FTSE 100 slump 30% by 20 March 2020 to hit a post-covid trough of 5190.78.”

“While the rebound was initially impressive, by June the rally has lost its momentum and it wasn’t until the first Covid vaccines were announced last November that it started to motor again.”

“A key reason why the FTSE 100 has found it so hard to recover all the lost territory is the type of stocks that have the biggest influence on the index’s performance. The FTSE 100 is market-cap weighted so the largest companies really matter when it comes to how the index moves.”

AstraZeneca

AstraZeneca is one such FTSE 100 heavyweight and the largest share by market cap (£139 billion), making up a significant part of the index.

Astra shares were down some 4% early on Friday and by far the biggest drag on the index after the company released their Q3 update.

Astra saw revenue soar and said they would start to take profit from the vaccine, but margin pressures spooked investors.

“The acquisition of Alexion means Astra’s sales numbers have soared. But impairments, additional operating costs post acquisition, new drug launches and the fact the groups still makes no profit on vaccine sales all mean profit margins are down substantially,” said Nicholas Hyett, Equity Analyst at Hargreaves Lansdown.

Supply chain efficiencies through automation and data science with GXO Logistics

The UK Investor Magazine is joined by Gavin Williams, Managing Director UK & Ireland, GXO Logistics. The focus of this podcast is to explore supply chain efficiencies through automation and data science.

GXO Logistics is a world leader in contract logistics and supply chain management. To deliver increased efficiencies to their clients GXO have developed a modular approach to automation and Gavin explains specific applications being used in the supply chain today.

We discuss the current state of the supply chain, the factors causing supply chain issues and how long it may take for shortages to diminish. Thankfully Gavin is confident we’ll all be receiving our Christmas presents this year.

UK vacancies reach 2.7m

0

The number of vacancies in the UK has now reached 2.7m according to the Recruitment and Employment Confederation (REC).

The first week of November saw 221,000 new jobs posted, which is the fourth highest weekly number since the start of 2020.

Most jobs posted were for driving instructors and forklift truck drivers whilst there was a fall in construction roles.

“The latest job advert numbers show recruitment activity staying strong in the run-up to Christmas,” said  Neil Carberry, chief executive.

“The general positive trend varies by region and sector, however. London has been affected more than other areas by the rise of hybrid working and its jobs market continues to grow at a slower pace than the rest of the UK.

“While roles in logistics and care are in high demand, the construction sector saw a drop-off last week as supply issues constrained the industry’s ability to work to capacity.

“It’s vital that, as the recovery continues, government put measures in place that will help companies invest with confidence, thereby increasing productivity and helping the economy to grow.

“That includes a revolution in the skills system, especially focused on helping those furthest from the labour market into work,” he added.

Alibaba sees record sales in China

0

Alibaba reported record sales amid the Singles Day shopping event.

The Chinese e-commerce group 540.3bn yuan (£63bn) spent by Chinese shoppers on the day that is similar to US Black Friday shopping.

Strong sales were in cosmetics, appliances and electronics. This is the first year that year-on-year growth failed to reach double digit growth.

Rui Ma from the Tech Buzz China explained: “It’s probably not that great if you consider the market is expected to grow at almost 12%. They’ve already tapped out this holiday to its extreme. This is already a big number so its hard to show growth,”

Alibaba shares were down 1%.

AstraZeneca revenues jump

0

AstraZeneca sales jumped 50% in the third quarter, whilst revenues were up 50% this quarter and 32% over the whole year.

The Covid-19 vaccine is now expected to become profitable. The group has sold 2.2 billion vaccines since the year started.

 “AstraZeneca’s scientific leadership continues to provide strong revenue growth and exceptional pipeline delivery, with eight positive late-stage readouts across seven medicines since June, including our long acting antibody combination showing promise in both prevention and treatment of COVID-19,” said Pascal Soriot, the chief executive officer.

“The addition of Alexion furthers our commitment to bring transformative therapies to patients around the world, and I am proud of our colleagues’ ongoing dedication and focus.”

Following the results, shares in the group were down 2.62% (0913GMT).

“AstraZeneca’s earnings reflect an impressive quarter for big pharma, but a wealth of growth drivers sets this company apart,” said Sebastian Skeet, Senior Analyst for healthcare sector clients at Third Bridge.

“Q3 2021 has seen a number of the big pharma cohort beat analyst estimates and raise Q3 guidance. This morning AstraZeneca did neither, missing analyst EPS estimates and maintaining guidance, despite reporting higher than expected product sales growth, at 32% CER excluding the vaccine, and 15% growth in core EPS. On a reported basis, AstraZeneca posted a loss, although this was mainly driven by the necessary investments to support the burgeoning pipeline.”

“AstraZeneca’s top-line beat was impressive, and in the context of continued vaccine rollouts, booster doses and the impressive data from Merck’s and Pfizer’s antiviral pills, perhaps this points to a normalisation of the market environment.”